What Researchers Did
Researchers investigated whether hyperbaric oxygen therapy could enhance the engraftment of human umbilical cord blood CD34⁺ cells in an immune-deficient mouse model.
What They Found
Hyperbaric oxygen (HBO) treated mice showed significantly improved retention and engraftment of human umbilical cord blood CD34⁺ cells in the bone marrow, peripheral blood, and spleen. Furthermore, HBO significantly enhanced the engraftment of human myeloid and B-cell subsets in these areas, with in vivo imaging confirming higher bioluminescence values in HBO-treated mice.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
A primary limitation of this study is that it was conducted in an immune-deficient mouse model, meaning the findings may not directly translate to human patients.